References
- Pearson T. C., Messinezy M. The diagnostic criteria of polycythaemia rubra Vera. Leukemia and Lymphoma 1996; 22(Suppl. 1)87–93
- Kutti J., Wadenvik H. Diagnostic and differential criteria of essential thrombocythaemia and reactive thombo-cytosis. Leukemia and Lymphoma 1996; 22(suppl. 1)41–45
- Erslev A. J., Caro J., Kansu E., Miller O., Cobbs E. Plasma erythropoietin in polycythemia. American Journal of Medicine 1979; 66: 243–248
- Cotes P. M., Dorie C. J., Yin J. A., Lewis S. M., Messinezy M., Pearson T. C., Reid C. Determination of serum immunoreactive erythropoietin in the investigation of erythrocytosis. New England Journal of Medicine 1986; 315: 283–287
- Birgegård G., Wide L. Serum erytropoietin in diagnosis of polycythaemia and after phlebotomy treatment. British Journal of Haematology 1992; 81: 603–606
- Carneskog J., Kutti J., Wadenvik H., Lundberg P. A., Lindstedt G. Plasma erythropoietin by high-detecta-bility immunoradiometric assay in untreated and treated patients with polycythaemia Vera and essential thrombocythaemia. European Journal of Haematology 1998; 60: 278–282
- Andréasson B., Carneskog J., Lindstedt G., Lundberg P. A., Swolin B., Wadenvik H., Kutti J. Plasma erythropoietin concentrations in polycythaemia Vera with special reference to myelosuppressive therapy. Leukemia and Lymphoma 1999, in press
- Viala J. J., Ville D., Sebban C., Assouline D., Devaux Y., Hanss M. Plasma erythropoietin in essential thrombocythaemia. Nouvelle Revue Franqaise d'Hematolo-gie 1993; 35: 423–424
- Murphy S., Iland H., Rosenthal D., Laszlo J. Essential trombocythaemia an interim report from the Polycythemia Vera Study Group. Seminars in Hematology 1986; 23: 177–182
- Najean Y., Schlageter M. H., Toubert M. E., Podgorniak M. P. Radioimmunoassay of immunoreactive erythropoietin as a clinical tool for the classification of polycythae-mias. Nouvelle Revue Française d'Hematologie. 1990; 32: 237–240
- Andréasson B., Swolin B., Kutti J. Hydroxyurea treatment reduces haematopoietic progenitor growth and CD 34 positive cells in polycythaemia Vera and essential thombo-cythaemia. European Journal of Haematology 1999, in press
- Yan L., Elkassar N., Gardin C., Brière J. Clonal-ity assays and megakaryocyte culture techniques in essential thrombocythemia. Leukemia and Lymphoma 1996; 22(suppl 1)31–40
- Harrison C. N., Gale R. E., Machin S. J., Linch D. C. A large proportion of patients with a diagnosis of essential thrombocythemia do not have clonal disorder and may be at a lower risk for thrombotic complications. Blood 1999; 93: 417–424
- Cortelazzo S., Viero P., Finazzi G., D'Emilio A., Rodeghi-ero F., Barbui T. Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. Journal of Clinical Oncology 1990; 8: 556–562
- Besses C., Cervantes F., Pereira A., Floresa L., Sole F., Hernandez-Boluda J. C., Woessner S., Sans-Sabrafen J., Roman C., Montserrat E. Major vascular complications in essential thrombocythemia: a study of the predictive factors in a series of 148 patients. Leukemia 1999; 13: 150–154
- Ruggeri M., Finazzi G., Tosetto A., Riva S., Rodeghiero F., Barbui T. No treatment for low-risk thrombocythaemia: results from a prospective study. British Journal of Haematology 1998; 103: 772–777